\
&
Contact us
\
&
Contact us
This was 1 year ago
LocationBrussels
ProgrammesThe Innovative Health Initiative will hold a brokerage event in Brussels on 12 & 13 November 2024.
The aim of the event is to provide people interested in IHI Call 9 for proposals with the opportunity to network face-to-face and start forming consortia. There will also be pitching sessions and poster sessions to give research organisations, patient groups and companies the chance to showcase their capabilities. Find the detailed agenda of the event here.
More information and registration for the brokerage event on the IHI website.
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.
